Clinical Outcomes and Survival Following Treatment of Metastatic Castrate …

Clinical Outcomes and Survival Following Treatment of Metastatic Castrate …

Bony metastatic castrate-refractory prostate cancer (CRPC) has a poor prognosis and high morbidity. Zoledronic acid (ZA) is commonly combined with docetaxel in practice but lacks evidence that combining is effective, and strontium-89 (Sr89) is

(Visited 1 times, 1 visits today)
2
Like
Save

Comments

Comments are disabled for this post.